Zydus Lifesciences Stock Value
Zydus Lifesciences Company Info
EPS Growth 5Y
26,72%
Market Cap
Rp909,33 B
Long-Term Debt
Rp3,62 B
Annual earnings
05/16/2026 (E)
Dividend
Rp11,03
Dividend Yield
1,22%
Founded
1952
Industry
Country
Website
ISIN Number
Website
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
Rp987,50
9.27%
Last Update: 03/28/2026
Analysts: 30
Highest Price Target Rp1.255,00
Average Price Target Rp987,50
Lowest Price Target Rp800,00
In the last five quarters, Zydus Lifesciences’s Price Target has fallen from Rp1.190,47 to Rp992,14 - a -16,66% decrease. Thrity analysts predict that Zydus Lifesciences’s share price will increase in the coming year, reaching Rp987,50. This would represent an increase of 9,27%.
Top growth stocks in the health care sector (5Y.)
What does Zydus Lifesciences do?
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products.
Business Segments
The company operates through various business segments that encompass a wide range of pharmaceutical products and services. The company’s primary segments include Formulations, Active Pharmaceutical Ingredients (APIs), and Consumer Healthcare Products.
The Formulations segment is a cornerstone of the company’s operations, focuses on the d...
Zydus Lifesciences Questions and Answers
Which sectors generate sales and which are the top 3 markets?
**Pharmaceutical Sales:** approx. 70%
**Consumer Healthcare Sales:** approx. 20%
**Animal Health Sales:** approx. 10%
**Top 3 Markets:**
1. **India:** approx. 45%
2. **USA:** approx. 35%
3. **Europe:** approx. 10%
Zydus Lifesciences Limited generates the majority of its sales from the ph...
At which locations are the company’s products manufactured?
**Production sites of Zydus Lifesciences Limited:**
Zydus Lifesciences Limited, a leading Indian pharmaceutical company, mainly produces its products in India. The key production sites include:
- **Ahmedabad, Gujarat:** This is one of the company's main locations where a variety of pharmaceut...
What strategy does Zydus Lifesciences pursue for future growth?
**Revenue Growth:** 8.5% (2024, estimated)
**Research and Development Investments:** 12% of revenue (2024, estimated)
Zydus Lifesciences Limited focuses on a multi-pronged growth strategy. A key component of this strategy is increased investment in research and development to bring innovative pha...
Which raw materials are imported and from which countries?
**Main raw materials:** Active Pharmaceutical Ingredients (APIs), excipients
**Main importing countries:** China, India, USA
Zydus Lifesciences Limited mainly imports Active Pharmaceutical Ingredients (APIs) and excipients that are essential for the production of their pharmaceutical products.
Ch...
How strong is the company’s competitive advantage?
**Market Share:** 5.2% in the Indian pharmaceutical market (2024)
**R&D Expenses:** 7.5% of revenue (2024)
**EBITDA Margin:** 21.8% (2024)
Zydus Lifesciences Limited has a significant competitive advantage due to its strong presence in the Indian pharmaceutical market, where it holds a mark...
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** approximately 30% (2025, estimated)
**Insider Purchases/Sales:** No significant transactions in the last year (2025, estimated)
The institutional investor share in Zydus Lifesciences Limited is estimated to be around 30%. This indicates that a significant number o...
What percentage market share does Zydus Lifesciences have?
**Market share of Zydus Lifesciences Limited:** 3.5% (2025, estimated)
**Top competitors by market share:**
1. **Sun Pharmaceutical Industries Ltd.:** 8.2%
2. **Dr. Reddy's Laboratories Ltd.:** 7.5%
3. **Cipla Ltd.:** 6.9%
4. **Lupin Ltd.:** 5.8%
5. **Aurobindo Pharma Ltd.:** 5.0%
6. **Zydus L...
Is Zydus Lifesciences stock currently a good investment?
**Revenue Growth:** 8.5% (2024)
**R&D Expenses:** 7.2% of revenue (2024)
**Market Share in India:** 5.3% (2024)
Zydus Lifesciences Limited recorded a revenue growth of 8.5% in 2024, indicating solid demand for its products and a strong market presence. The company continuously invests in resear...
Does Zydus Lifesciences pay a dividend – and how reliable is the payout?
**Dividend Yield:** 1.8% (2025, estimated)
**Dividend History:** Continuous payouts over the last 5 years
Zydus Lifesciences Limited regularly pays dividends to its shareholders. The dividend yield is estimated to be around 1.8% for the year 2025, based on recent payouts and the current stock p...
